SA
AMAG

SRH Advisors’s AMAG Pharmaceuticals AMAG Stock Holding History

SRH Advisors’s Portfolio AMAG Stock Details AMAG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-250
Closed -$3K – 281
2019
Q4 		$3K Sell
250
-1,500
-86% -$16.4K 0.01% 233
2019
Q3 		$20K Hold
1,750
– – 0.07% 124
2019
Q2 		$17K Hold
1,750
– – 0.06% 135
2019
Q1 		$23K Sell
1,750
-1,250
-42% -$18.6K 0.08% 110
2018
Q4 		$46K Hold
3,000
– – 0.18% 80
2018
Q3 		$60K Hold
3,000
– – 0.21% 75
2018
Q2 		$59K Buy
+3,000
New +$66.4K 0.22% 75

Other funds holding AMAG

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

SRH Advisors's AMAG Position: Q1 2020 in Review

SRH Advisors sold out of AMAG Pharmaceuticals (AMAG) in Q1 2020, closing a stake of 250 shares — an estimated $3K sold.

SRH Advisors first reported a position in AMAG in Q2 2018 and held it in 7 quarters. The position peaked at $60K in Q3 2018. 119 funds tracked by Wall St. Rank hold AMAG as of Q1 2020.

  • SRH Advisors reported no remaining AMAG Pharmaceuticals position as of Q1 2020 after selling out during the quarter.
  • SRH Advisors sold 250 AMAG Pharmaceuticals shares in Q1 2020, an estimated $3K.
  • SRH Advisors first reported a position in AMAG Pharmaceuticals in Q2 2018 and held it in 7 quarters.
  • SRH Advisors's AMAG Pharmaceuticals position peaked at $60K in Q3 2018.
  • 119 funds tracked by Wall St. Rank held AMAG Pharmaceuticals as of Q1 2020.

Based on SRH Advisors's 13F filing for Q1 2020, filed 29 Apr 2020.